Conformis Struggles with Supply for New Products
The company's product revenue declined in the low-single digits for 2Q22 while supply chain disruption impacted three new products. Aug 10, 2022
ATEC’s Procedural Focus Brings More Wins in Second Quarter
The company grew more than 35% in 2Q22, driven by accelerating adoption of the ATEC's PTP procedure and growing EOS placements. Aug 10, 2022
Globus Medical Notches Sales Records in Second Quarter
The company grew in the mid-single digits against a difficult comparison, notching its highest revenue quarter and June ever. Aug 09, 2022
Anika Works Through Distributor Disruptions in Solid Second Quarter
The company grew in the mid-single digits for 2Q22, driven by favorable order timing for its joint pain management business. Aug 09, 2022
Enovis Remains on Target for 2022 Growth Goals
The company's orthopedic revenue grew nearly 40% in the second quarter of 2022 on the strength of recent acquisitions like Mathys. Aug 08, 2022
Paragon 28 Drives Growth with New Product Cadence
Company sales grew almost 19% in 2Q22 as Paragon 28 closed portfolio gaps, expanded its sales force and grew its surgeon population. Aug 08, 2022
SeaSpine’s Growing Portfolio Drives Share Gains
The company grew in the high teens for 2Q22 as its expanding portfolio and 7D unit placements drove market share gains. Aug 05, 2022
Vericel Anticipates Strong Second Half for MACI
The company grew in the high-single digits in 2Q22, representing the highest MACI revenue total outside of fourth quarters since launch. Aug 05, 2022
NuVasive Sees Increased Volume and Demand in Second Quarter
The company grew in the mid-single digits for 2Q22 as it benefitted from increased volume in newer product categories. Aug 04, 2022
Zimmer Biomet Exceeds Expectations with Second Quarter Performance
The company grew in the low single digits for 2Q22 despite market headwinds and raised its full-year 2022 guidance. Aug 03, 2022
